牛皮:关于局部和全身治疗的最新情况
Jonathan J Chan1,2,3
1Sir Charles Gairdner Hospital, Perth.
Australian prescriber
|June 26, 2025
概括
牛皮是一种慢性,免疫媒介疾病,影响皮肤和潜在的其他器官. 在传统治疗失败后,较新的生物疗法可为严重的牛皮提供显著的缓解症状.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 系统性炎症性疾病系统性炎症性疾病
- 遗传学 是一个遗传学.
背景情况:
- 牛皮是一种免疫媒介的炎症性疾病,具有遗传联系.
- 它主要影响皮肤,但是全身性的,与关节炎,心血管疾病和抑郁症等并发症有关.
- 对慢性和并发性疾病的患者教育对于管理至关重要.
研究的目的:
- 概述牛皮的管理,从局部疗法到先进的全身治疗.
- 突出新疗法在解决牛皮系统性质方面的作用.
- 强调使用先进治疗方法显著缓解症状的潜力.
主要方法:
- 审查当前的牛皮管理策略.
- 基于疾病严重程度和患者症状的治疗升级的讨论.
- 传统的全身疗法 (甲基) 和光疗的概述.
- 介绍新的向疗法,包括口服和生物药物.
主要成果:
- 局部治疗适用于有限的,非全身性牛皮.
- 光疗和传统的全身性药物,如甲醇,用于更广泛的疾病.
- 生物和口服疗法只适用于对传统治疗无反应的病例.
- 生物疗法显示出几乎完全解决症状的潜力.
结论:
- 牛皮的管理需要根据疾病的程度和系统参与而采取量身定制的方法.
- 先进的疗法,特别是生物药物,为严重或耐火性牛皮提供了有效的选择.
- 了解牛皮作为一种慢性,全身性疾病和并发症是最佳患者护理的关键.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
204
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Changes in Skin Color: Clinical Perspectives
2.3K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
239
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
239
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
277
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
277


